AXT Pty Ltd

AXT have recently installed a Rigaku benchtop computed tomography system at an industrial site in New Zealand. This is the first installation of its type in the Oceania region.

AXT have recently been appointed distributor for Luxonus' 3D photoacoustic imager. This next-generation medical imaging technology generates more data, in greater detail, with less risk for patients and is ideal for medical research.

AXT have strengthened their 3D printing portfolio with the addition of Exaddon, a Swiss-based manufacturer of metal additive manufacturing systems. Their CERES system produces components from 1-1000 microns with sub-micron resolution.

AXT is proud to bring the range of ultra-high resolution 3D printers from Boston Micro Fabrication (BMF) to Australia and New Zealand.

AXT have a strong commitment to the microscopy community and are always looking out for new and innovative products that can enhance microscopy research and workflows.

AXT has furthered its commitment to the bioprinting and microfabrication communities by adding the unique UpNano portfolio of products to their range.

The COVID-19 pandemic is crippling the world and its full effects will not be felt for many years to come. Researchers have scrambled to characterize the SARS-CoV2 virus so they can help develop a vaccine for this insidious disease.

The surface science capabilities at the Australian institute for Innovative Materials (AIIM) at the University of Wollongong (UoW) have recently been upgraded with the installation of a highly versatile Thermo Scientific NEXSA XPS (X-ray Photoelectron...

Bioprinting holds enormous promise in medicine in areas such as tissue engineering, regenerative medicine and drug discovery.

The Victorian Cancer Biobank (VCB) is a crucial part of the medical research landscape supporting researchers throughout Australia and around the world with the aim of delivering better clinical outcomes to people suffering with cancer.